LABORATORIOS FARMACEUTICOS ROVI SA 17/06/2026 AGM
1Approve Consolidated and Standalone Financial StatementsFor
2Approve Non-Financial StatementsFor
3Approve the Dividend of EUR 0.9594 per ShareFor
4Discharge the BoardFor
5Re-elect Marina del Corral Téllez - Non-Executive DirectorOppose
6Approve Maximum Annual Board Remuneration of EUR 1.1 MillionFor
7.1Re-appoint the Auditors, KPMGOppose
7.2Re-appoint the Auditors KPMG for FY 2027-2029 Oppose
8Authorise the Board to Ratify and Execute Approved ResolutionsFor
9Approve the Remuneration ReportAbstain